133 related articles for article (PubMed ID: 20457672)
1. Effects of the calpain inhibitor MDL28170 on the clinically relevant forms of Trypanosoma cruzi in vitro.
Ennes-Vidal V; Menna-Barreto RF; Santos AL; Branquinha MH; d'Avila-Levy CM
J Antimicrob Chemother; 2010 Jul; 65(7):1395-8. PubMed ID: 20457672
[TBL] [Abstract][Full Text] [Related]
2. MDL28170, a calpain inhibitor, affects Trypanosoma cruzi metacyclogenesis, ultrastructure and attachment to Rhodnius prolixus midgut.
Ennes-Vidal V; Menna-Barreto RF; Santos AL; Branquinha MH; d'Avila-Levy CM
PLoS One; 2011 Apr; 6(4):e18371. PubMed ID: 21483751
[TBL] [Abstract][Full Text] [Related]
3. The potent cell permeable calpain inhibitor MDL28170 affects the interaction of Leishmania amazonensis with macrophages and shows anti-amastigote activity.
Marinho FA; Sangenito LS; Oliveira SSC; De Arruda LB; D'Ávila-Levy CM; Santos ALS; Branquinha MH
Parasitol Int; 2017 Oct; 66(5):579-583. PubMed ID: 28663009
[TBL] [Abstract][Full Text] [Related]
4. Effect of L-leucine methyl ester on growth and ultrastructure of Trypanosoma cruzi.
Adade CM; Figueiredo RC; De Castro SL; Soares MJ
Acta Trop; 2007 Jan; 101(1):69-79. PubMed ID: 17250794
[TBL] [Abstract][Full Text] [Related]
5. Multiple effects of pepstatin A on Trypanosoma cruzi epimastigote forms.
Sangenito LS; Gonçalves KC; Abi-Chacra EA; Sodré CL; d'Avila-Levy CM; Branquinha MH; Santos AL
Parasitol Res; 2012 Jun; 110(6):2533-40. PubMed ID: 22205353
[TBL] [Abstract][Full Text] [Related]
6. Susceptibility of promastigotes and intracellular amastigotes from distinct Leishmania species to the calpain inhibitor MDL28170.
de Sousa Araújo PS; de Oliveira SSC; d'Avila-Levy CM; Dos Santos ALS; Branquinha MH
Parasitol Res; 2018 Jul; 117(7):2085-2094. PubMed ID: 29728827
[TBL] [Abstract][Full Text] [Related]
7. HIV aspartic peptidase inhibitors are effective drugs against the trypomastigote form of the human pathogen Trypanosoma cruzi.
Sangenito LS; Gonçalves DS; Seabra SH; d'Avila-Levy CM; Santos AL; Branquinha MH
Int J Antimicrob Agents; 2016 Oct; 48(4):440-4. PubMed ID: 27499433
[TBL] [Abstract][Full Text] [Related]
8. Arrested growth of Trypanosoma cruzi by the calpain inhibitor MDL28170 and detection of calpain homologues in epimastigote forms.
Sangenito LS; Ennes-Vidal V; Marinho FA; Da Mota FF; Santos AL; D'Avila-Levy CM; Branquinha MH
Parasitology; 2009 Apr; 136(4):433-41. PubMed ID: 19250597
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo studies of the trypanocidal activity of a diarylthiophene diamidine against Trypanosoma cruzi.
da Silva CF; Batista MM; Batista Dda G; de Souza EM; da Silva PB; de Oliveira GM; Meuser AS; Shareef AR; Boykin DW; Soeiro Mde N
Antimicrob Agents Chemother; 2008 Sep; 52(9):3307-14. PubMed ID: 18625779
[TBL] [Abstract][Full Text] [Related]
10. Effect of usnic acid from the lichen Cladonia substellata on Trypanosoma cruzi in vitro: an ultrastructural study.
De Carvalho EA; Andrade PP; Silva NH; Pereira EC; Figueiredo RC
Micron; 2005; 36(2):155-61. PubMed ID: 15629646
[TBL] [Abstract][Full Text] [Related]
11. Pentamidine exerts in vitro and in vivo anti Trypanosoma cruzi activity and inhibits the polyamine transport in Trypanosoma cruzi.
Díaz MV; Miranda MR; Campos-Estrada C; Reigada C; Maya JD; Pereira CA; López-Muñoz R
Acta Trop; 2014 Jun; 134():1-9. PubMed ID: 24560964
[TBL] [Abstract][Full Text] [Related]
12. Effects of a marine serine protease inhibitor on viability and morphology of Trypanosoma cruzi, the agent of Chagas disease.
de Almeida Nogueira NP; Morgado-Díaz JA; Menna-Barreto RF; Paes MC; da Silva-López RE
Acta Trop; 2013 Oct; 128(1):27-35. PubMed ID: 23770204
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo antiparasitic activity of Physalis angulata L. concentrated ethanolic extract against Trypanosoma cruzi.
Meira CS; Guimarães ET; Dos Santos JA; Moreira DR; Nogueira RC; Tomassini TC; Ribeiro IM; de Souza CV; Ribeiro Dos Santos R; Soares MB
Phytomedicine; 2015 Oct; 22(11):969-74. PubMed ID: 26407938
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo studies of the trypanocidal properties of WRR-483 against Trypanosoma cruzi.
Chen YT; Brinen LS; Kerr ID; Hansell E; Doyle PS; McKerrow JH; Roush WR
PLoS Negl Trop Dis; 2010 Sep; 4(9):. PubMed ID: 20856868
[TBL] [Abstract][Full Text] [Related]
15. In vitro trypanocidal activity of DB745B and other novel arylimidamides against Trypanosoma cruzi.
Da Silva CF; Junqueira A; Lima MM; Romanha AJ; Sales Junior PA; Stephens CE; Som P; Boykin DW; Soeiro Mde N
J Antimicrob Chemother; 2011 Jun; 66(6):1295-7. PubMed ID: 21478242
[TBL] [Abstract][Full Text] [Related]
16. In vitro activities of adamantylidene-substituted alkylphosphocholine TCAN26 against Trypanosoma cruzi: Antiproliferative and ultrastructural effects.
Barrias E; Reignault LC; Calogeropoulou T; de Souza W
Exp Parasitol; 2019 Nov; 206():107730. PubMed ID: 31494215
[TBL] [Abstract][Full Text] [Related]
17. In vitro biological evaluation of eight different essential oils against Trypanosoma cruzi, with emphasis on Cinnamomum verum essential oil.
Azeredo CM; Santos TG; Maia BH; Soares MJ
BMC Complement Altern Med; 2014 Aug; 14():309. PubMed ID: 25148924
[TBL] [Abstract][Full Text] [Related]
18. Decoding the anti-Trypanosoma cruzi action of HIV peptidase inhibitors using epimastigotes as a model.
Sangenito LS; Menna-Barreto RF; D Avila-Levy CM; Santos AL; Branquinha MH
PLoS One; 2014; 9(12):e113957. PubMed ID: 25464510
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo activities of 1,3,4-thiadiazole-2-arylhydrazone derivatives of megazol against Trypanosoma cruzi.
Salomão K; de Souza EM; Carvalho SA; da Silva EF; Fraga CA; Barbosa HS; de Castro SL
Antimicrob Agents Chemother; 2010 May; 54(5):2023-31. PubMed ID: 20231395
[TBL] [Abstract][Full Text] [Related]
20. Interaction of bloodstream, tissue culture-derived and axenic culture-derived trypomastigotes of Trypanosoma cruzi with macrophages.
Meirelles MN; Chiari E; de Souza W
Acta Trop; 1982 Sep; 39(3):195-203. PubMed ID: 6128888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
